Outlook Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $71,703,235,000,000.

Profit Margin

Outlook Therapeutics, Inc. (NASDAQ:OTLK): Profit margin
2015 5.21M -47.39M -908.05%
2016 2.97M -53.32M -1789.83%
2017 3.81M -38.84M -1019.26%
2018 3.08M -46.11M -1493.57%
2019 8.14M -34.52M -423.81%
2020 0 -35.23M
2021 0 -53.16M
2022 0 -66.05M
2023 0 -58.98M
2024 0 -75.36T

OTLK Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
000008.14M3.08M3.81M2.97M5.21M
Cost of revenue
044.18K204.69K262.13K554.06K23.80K18.50K23.80K32.76K38.87K
Gross profit
0-44.18K-204.69K-262.13K-554.06K8.12M3.06M3.78M2.94M5.18M
Operating exp.
Research and development
41.76T26.45M42.33M38.95M26.34M23.80M18.50M23.80M32.76M38.87M
Selling and marketing
000279.67K-1.89M-3.84M-7.25M-2.69M-2.46M0
Total operating expenses
71.70T53.12M63.07M51.72M36.31M29.32M25.47M39.69M51.93M51.78M
Operating income
-71.70T-53.12M-63.07M-51.72M-36.84M-36.29M-25.44M-35.88M-51.75M-46.56M
Other income (expenses), net
-3.66T-5.85M-2.97M-1.43M-1.67M-1.63M-8.29M-2.46M-1.46M-2.29M
Income before tax
-75.36T-58.97M-66.04M-53.16M-38.51M-37.93M-33.74M-38.34M-53.22M-48.85M
Income tax expense
2.8B2.8K2.8K2K-3.27M-3.41M-3.64M501.5K103K-190.11K
Net income
-75.36T-58.98M-66.05M-53.16M-35.23M-34.52M-46.11M-38.84M-53.32M-47.39M
Earnings per share
Basic EPS
-4.06K-4.72-6.23-6.96-9.71-37.96-50.7-258.75-24.79-504.47
Diluted EPS
-4.06K-4.72-6.23-6.96-9.71-37.96-50.7-258.54-24.79-504.47
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source